Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Multi-antigen CMV-modified vaccinia Ankara vaccine |
Synonyms | |
Therapy Description |
Multi-antigen CMV-modified vaccinia Ankara vaccine is viral-based vaccine engineered to express three cytomegalovirus (CMV) antigens, which may induce a CMV-specific immune response (PMID: 27760761, PMID: 35272066). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Multi-antigen CMV-modified vaccinia Ankara vaccine | CMV-MVA Triplex Vaccine|CMV-Modified Vaccinia Ankara Vaccine | Multi-antigen CMV-modified vaccinia Ankara vaccine is viral-based vaccine engineered to express three cytomegalovirus (CMV) antigens, which may induce a CMV-specific immune response (PMID: 27760761, PMID: 35272066). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|